| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |